Global histone modification patterns as prognostic markers to classify glioma patients.
about
Histone acetyltransferases: challenges in targeting bi-substrate enzymesGlobal histone post-translational modifications and cancer: Biomarkers for diagnosis, prognosis and treatment?Developing epigenetic diagnostics and therapeutics for brain disordersAltered histone modifications in gliomasEpigenome-Wide Association Studies (EWAS) in CancerThe role of epigenetics in resistance to Cisplatin chemotherapy in lung cancerEmerging role of linker histone variant H1x as a biomarker with prognostic value in astrocytic gliomas. A multivariate analysis including trimethylation of H3K9 and H4K20.Opportunities and challenges for selected emerging technologies in cancer epidemiology: mitochondrial, epigenomic, metabolomic, and telomerase profiling.Is glioblastoma an epigenetic malignancy?SIRT7, H3K18ac, and ELK4 Immunohistochemical Expression in Hepatocellular Carcinoma.Histone onco-modifications.Unraveling the glioma epigenome: from molecular mechanisms to novel biomarkers and therapeutic targets.Valproic acid for the treatment of malignant gliomas: review of the preclinical rationale and published clinical results.The good, the bad and the ugly: epigenetic mechanisms in glioblastoma.Deregulated chromatin remodeling in the pathobiology of brain tumors.An update on the epigenetics of glioblastomas.Therapeutic Targeting of Histone Modifications in Adult and Pediatric High-Grade Glioma.Association between H3K4 methylation and cancer prognosis: A meta-analysis.
P2860
Q26745642-6326F4C7-0C1D-484C-A77F-62C177955312Q26775413-F16270B3-E4F2-417E-B4C2-935A477949D8Q27022987-58B39BC3-399F-4C8D-B00B-42AA2958023AQ27027924-7336639D-9B78-488A-9D91-F9F22713C124Q28310536-1CF5347F-345C-4E2C-B15D-BEF2F98CC4A5Q28387891-CC9BB28D-946C-4B18-BEEE-ECC8E8B9B632Q34989552-D4568A51-806A-43B3-B826-BF9047427BD9Q36589155-1221F5B3-51AF-4096-9BE0-E21346AFF494Q37226526-31FEF006-2652-44E9-8D65-6340B919863EQ37297802-A287E0CA-DFF0-4378-A9B1-F30AC9269EAAQ37868421-36AFBF88-CCD4-49DA-847F-329C59DB8B82Q37937061-BA6C987F-8EAF-460C-802D-FD71E9F48002Q38016227-C9D7DF73-EA2E-455F-907C-4C012AED3B7DQ38024560-122397D3-12E8-4E12-8FE0-45E19A26094CQ38056842-012A81D0-F911-413C-9A82-59B045509052Q38944047-22D086CF-DBE4-4DAC-B652-7E3AB048AB2AQ39236500-4DB88BD6-264B-4442-82A4-AC6347312659Q55516303-E7C615C2-93B2-424E-B1DE-C74673852025
P2860
Global histone modification patterns as prognostic markers to classify glioma patients.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Global histone modification patterns as prognostic markers to classify glioma patients.
@ast
Global histone modification patterns as prognostic markers to classify glioma patients.
@en
type
label
Global histone modification patterns as prognostic markers to classify glioma patients.
@ast
Global histone modification patterns as prognostic markers to classify glioma patients.
@en
prefLabel
Global histone modification patterns as prognostic markers to classify glioma patients.
@ast
Global histone modification patterns as prognostic markers to classify glioma patients.
@en
P2093
P1476
Global histone modification patterns as prognostic markers to classify glioma patients.
@en
P2093
Bo-lin Liu
Hong Cheng
Jin-xiang Cheng
Xiang Zhang
Xiao-yan Chen
P304
P356
10.1158/1055-9965.EPI-10-0454
P577
2010-09-14T00:00:00Z